Teneobio, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Teneobio, Inc.

Patent Number:
Title:
Il2Rbeta/Common Gamma Chain Antibodies
Opposition Date:
Jun 30, 2021
Patent Number:
Title:
Binding Molecules For Bcma And Cd3
Applicant:
Opposition Date:
Jun 10, 2020

Want to track Teneobio, Inc.?

Feel free to send us a message here and we will get back to you